Clinical Observations| Volume 60, P54-59.e1, July 2016

Effect of Serotonin 1A Agonists and Selective Serotonin Reuptake Inhibitors on Behavioral and Nighttime Respiratory Symptoms in Rett Syndrome



      Rett syndrome is characterized by psychomotor regression during early childhood, autistic-like behaviors, and aberrant breathing patterns. Dysfunction of the serotonergic system has been postulated to play a role in the pathophysiology of these symptoms.

      Patient Description

      We present an 11-year-old girl with Rett syndrome who exhibited marked respiratory symptoms, including frequent apneic events during sleep. She had been treated for these respiratory symptoms using noninvasive positive pressure ventilation since age six years. Treatment with serotonin 1A receptor agonist was initiated at age eight years, whereas treatment using a selective serotonin reuptake inhibitor began at age nine years. Noninvasive positive pressure ventilation therapy was effective in reducing symptoms of sleep apnea, and administration of serotonergic agents resulted in amelioration of sleep apneic events even in the absence of noninvasive positive pressure ventilation. In addition, improvements in hand stereotypy and social skills were observed after initiation of serotonin-based therapy.


      The respiratory difficulties our patient experienced during non-rapid eye movement (REM) sleep are characteristic of post-sigh central apnea. Exaggerated activity of expiratory neurons during such apneic events has been observed in mouse models of Rett syndrome. We suggest that prescribed serotonergic agents might serve to inhibit such activity, attenuating the imbalance between inspiratory and expiratory neurons. These agents might also be useful in the treatment of autistic-like behaviors caused by impaired serotonergic transmission in the brain.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Pediatric Neurology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Julu P.O.
        • Kerr A.M.
        • Apartopoulos F.
        • et al.
        Characterisation of breathing and associated central autonomic dysfunction in the Rett disorder.
        Arch Dis Child. 2001; 85: 29-37
        • Hagebeuk E.E.
        • Bijlmer R.P.
        • Koelman J.H.
        • Poll-The B.T.
        Respiratory disturbances in Rett syndrome: don't forget to evaluate upper airway obstruction.
        J Child Neurol. 2012; 27: 888-892
        • Weese-Mayer D.E.
        • Lieske S.P.
        • Boothby C.M.
        • Kenny A.S.
        • Bennett H.L.
        • Ramirez J.M.
        Autonomic dysregulation in young girls with Rett syndrome during nighttime in-home recordings.
        Pediatr Pulmonol. 2008; 43: 1045-1060
        • Gökben S.
        • Ardıç U.A.
        • Serdaroğlu G.
        Use of buspirone and fluoxetine for breathing problems in Rett syndrome.
        Pediatr Neurol. 2012; 46: 192-194
        • Andaku D.K.
        • Mercadante M.T.
        • Schwartzman J.S.
        Buspirone in Rett syndrome respiratory dysfunction.
        Brain Dev. 2005; 27: 437-438
        • Dunn H.G.
        Importance of Rett syndrome in child neurology.
        Brain Dev. 2001; 23: S38-S43
        • Ramirez J.M.
        • Ward C.S.
        • Neul J.L.
        Breathing challenges in Rett syndrome: lessons learned from humans and animal models.
        Respir Physiol Neurobiol. 2013; 189: 280-287
        • Abdala A.P.
        • Dutschmann M.
        • Bissonnette J.M.
        • Paton J.F.
        Correction of respiratory disorders in a mouse model of Rett syndrome.
        Proc Natl Acad Sci U S A. 2010; 107: 18208-18213
        • Toward M.A.
        • Abdala A.P.
        • Knopp S.J.
        • Paton J.F.
        • Bissonnette J.M.
        Increasing brain serotonin corrects CO2 chemosensitivity in methyl-CpG-binding protein 2 (Mecp2)-deficient mice.
        Exp Physiol. 2013; 98: 842-849
        • Voituron N.
        • Zanella S.
        • Menuet C.
        • Lajard A.M.
        • Dutschmann M.
        • Hilaire G.
        Early abnormalities of post-sigh breathing in a mouse model of Rett syndrome.
        Respir Physiol Neurobiol. 2010; 170: 173-182
        • Lalley P.M.
        • Bischoff A.M.
        • Richter D.W.
        Serotonin 1A-receptor activation suppresses respiratory apneusis in the cat.
        Neurosci Lett. 1994; 172: 59-62
        • Alvarez J.E.
        • Bodani J.
        • Fajardo C.A.
        • Kwiatkowski K.
        • Cates D.B.
        • Rigatto H.
        Sighs and their relationship to apnea in the newborn infant.
        Biol Neonate. 1993; 63: 139-146
        • Fukumizu M.
        • Kohyama J.
        Central respiratory pauses, sighs, and gross body movements during sleep in children.
        Physiol Behav. 2004; 82: 721-726
        • Cherniack N.S.
        • von Euler C.
        • Głogowska M.
        • Homma I.
        Characteristics and rate of occurrence of spontaneous and provoked augmented breaths.
        Acta Physiol Scand. 1981; 111: 349-360
        • Nomura Y.
        Early behavior characteristics and sleep disturbance in Rett syndrome.
        Brain Dev. 2005; 27: S35-S42
        • Santos M.
        • Summavielle T.
        • Teixeira-Castro A.
        • et al.
        Monoamine deficits in the brain of methyl-CpG binding protein 2 null mice suggest the involvement of the cerebral cortex in early stages of Rett syndrome.
        Neuroscience. 2010; 170: 453-467